(15S,16E)-16,17,20,21-Tetradehydro-16-formyl-18,19-secoyohimban-19-oic acid methyl ester (5523-37-5)

Identification
Name:	(15S,16E)-16,17,20,21-Tetradehydro-16-formyl-18,19-secoyohimban-19-oic acid methyl ester
Synonyms:	(15S,16E)-16,17,20,21-Tetradehydro-16-formyl-18,19-secoyohimban-19-oic acid methyl ester;Vallesiachotamine
CAS:	5523-37-5
Molecular Formula:	C₂₁H₂₂N₂O₃
Molecular Weight:	350.41098
InChI:	InChI=1S/C21H22N2O3/c1-3-13(12-24)16-10-19-20-15(14-6-4-5-7-18(14)22-20)8-9-23(19)11-17(16)21(25)26-2/h3-7,11-12,16,19,22H,8-10H2,1-2H3/b13-3-/t16-,19?/m0/s1
Molecular Structure:
Properties
Density:	1.28 g/cm3
Safety Data

Other Product

(15β,16E)-16,17,20,21-Tetradehydro-16-(hydroxymethyl)-18,19-secoyohimban-19-oic acid methyl ester
(15α,20ξ)-16-Methyl-18,19-secoyohimban-19-oic acid methyl ester
(3β)-16,17,19,20-Tetradehydro-10,11-dimethoxy-19-methyl-18-oxayohimban-16-carboxylic acid methyl ester
methyl (19beta)-19-methyl-16,17,20,21-tetradehydro-18-oxayohimban-16-carboxylate
methyl (19alpha)-19-methyl-16,17,20,21-tetradehydro-18-oxayohimban-16-carboxylate
(3β,16E)-16,17,18,19-Tetradehydro-17-methoxycorynan-16-carboxylic acid methyl ester
(3β,16E,20β)-16,17,18,19-Tetradehydro-17-methoxycorynan-16-carboxylic acid methyl ester
Kaur-16-en-19-oic acid methyl ester
(15β)-20,21-Didehydro-16β-(hydroxymethyl)-18,19-secoyohimban-19-oic acid methyl ester
Oxayohimban-21-one,14,15,19,20-tetradehydro-16-ethenyl-17-(b-D-glucopyranosyloxy)-19-hydroxy-, (3b,16a,17b)- (9CI)
11,15-Dihydroxy-16-kauren-19-oic acid
Oxayohimbanium, 3,4,16,17-tetradehydro-16-(methoxycarbonyl)-19-methyl-, (19a)- (9CI)
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
Oxayohimban-16-carboxylic acid,16,17-didehydro-19-(â-Dglucopyranosyloxy)- 21-(hydroxymethyl)-,methyl ester,(19R,20R)-
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
(19S)-19-Acetyloxy-2,16-didehydro-20-hydroxycuran-17-oic acid methyl ester